Investor Relations

Our aim is to strengthen Siegfried's standing and credibility in the public and to enhance long-term enterprise value. As our focus is on transparency, we disclose all relevant information to facilitate comprehensive assessment of the company. 

There are many good reasons to invest in Siegfried:

  • Siegfried is the global industry leading Custom Manufacturing Organization (API) and one of two important integrated partners of the pharma industry (Drug Substances and Drug Products).
  • Critical size thanks to with 2300 employees generating sales of > CHF 500M
  • Focus on core business and USP: one-stop-shop for primary and secondary manufacturing
  • Globally efficient manufacturing (9 sites on 3 continents, incl. Asia)
  • Alignment of business and asset strategy
  • Broad technology base through acquisition and investments (new site in Nantong, high potency in Zofingen and Malta, spray drying in Pennsville)
  • Solid cash flows in all businesses; working capital performance and expense control
  • Variabilization of costs
  • High "natural hedge" as a priority of risk management
  • Sound financing structure with credit facility of a syndicate of Swiss banks
  • Continuous growth, organic and through acquisition


Siegfried AG
Peter A. Gehler
Chief Communication Officer
Untere Bruehlstrasse 4
4800 Zofingen

Phone +41 62 746 1148

Siegfried AG
Reto Suter, CFO
Untere Bruehlstrasse 4
4800 Zofingen

Phone +41 62 746 1135

to the top to top

Can't find the information
you are looking for?
Contact us

Siegfried AG
Untere Bruehlstrasse 4
CH-4800 Zofingen

Phone: +41 62 746 1111
Fax: +41 62 746 1202